Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal smooth muscle ion channels are a heterogeneous group of transmembrane proteins that orchestrate the electrical and mechanical activities of the digestive tract. These channels, which include voltage-gated calcium (e.g., Cav1.2), sodium (e.g., Nav1.5), and various potassium and chloride channels (e.g., ANO1), are expressed in smooth muscle cells and Interstitial Cells of Cajal (ICC) to regulate membrane potential and rhythmic contractions (Sanders et al., 2012; PubMed). They play a critical role in generating slow waves and mediating the response to neurotransmitters and hormones, thereby controlling peristalsis and transit (Beyder & Farrugia, 2012; NIH). Mutations or expression changes in these channels are implicated in functional gastrointestinal disorders (FGIDs) like irritable bowel syndrome (IBS) and gastroparesis, where they contribute to dysmotility and visceral hypersensitivity (Mazzone et al., 2011; PubMed). Therapeutic agents targeting these channels, such as calcium channel blockers (e.g., pinaverium) or sodium channel modulators, aim to restore normal motility and alleviate pain (Camilleri, 2018; StatPearls). However, drug development is often complicated by the high homology between GI ion channels and those in the heart or skeletal muscle, necessitating high tissue specificity to avoid systemic adverse effects like hypotension or arrhythmia (Farrugia & Beyder, 2016; PubMed).
Modulation of ion conductance (calcium, sodium, potassium, or chloride) across the sarcolemma of smooth muscle cells or Interstitial Cells of Cajal to alter excitability and contractility.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal smooth muscle ion channels.